http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2012154341-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C229-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C229-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J23-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C227-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C227-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C227-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C227-10
filingDate 2011-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2014-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2012154341-A
titleOfInvention METHOD FOR PRODUCING A MIXTURE OF CHELATING AGENTS
abstract 1. A method of obtaining a mixture of aspartic acid diethoxysuccinate and an amino acid derivative of the general formula where n is 1-10, m is 0 or 1, and R is a hydrogen atom or an alkali or alkaline earth metal ion, including the interaction of a maleate with diethanolamine under alkaline conditions in the presence of a lanthanide catalyst with the formation of aspartic acid diethoxysuccinate, then the addition of aspartic acid, which reacts with the unreacted maleate to form iminoduccinic acid, i.e. producing an amino acid of formula I, where m is 0, or the addition of a diamine derivative of the general formula where n is as defined above, which reacts with an unreacted maleate to form an amino acid derivative of the formula I, where m is 1 and n is as defined above. 2. The method according to claim 1, characterized in that the amount of diethanolamine is in a stoichiometric ratio with the amount of maleate. The method according to claim 2, characterized in that the molar ratio of diethanolamine to maleate is from 1: 3.1 to 1: 5, preferably from 1: 3.5 to 1: 4.4. The method according to claim 1, characterized in that the maleate and diethanolamine are reacted for a period of time sufficient to convert at least 30 mol% of diethanolamine to aspartic acid diethoxy succinate. The method according to claim 1, characterized in that the molar ratio of lanthanide catalyst to maleate is from 1: 2.5 to 1: 5, preferably from 1: 3 to 1: 4.6. The method according to claim 1, characterized in that the lanthanide catalyst is a lanthanum catalyst comprising lanthanum (III) oxide and lanthanum (III) salts. The method according to claim 6, where the lanthanum (III) salts are selected from the group
priorityDate 2010-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523914
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559568
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5960
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451126738
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID168924
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID150906
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87164003
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419584662
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24943465
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451361835
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64735
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523138
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19660
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559368
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104897
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25122
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID157578766
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419539584
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7923
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450202596
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419583168
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID961
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8113
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5288227
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23926
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520483
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448146635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448942573
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559376
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430863909
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450964499
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID219037
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3301
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419577485

Total number of triples: 51.